Cargando…

Tenascin-C drives persistence of organ fibrosis

The factors responsible for maintaining persistent organ fibrosis in systemic sclerosis (SSc) are not known but emerging evidence implicates toll-like receptors (TLRs) in the pathogenesis of SSc. Here we show the expression, mechanism of action and pathogenic role of endogenous TLR activators in ski...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhattacharyya, Swati, Wang, Wenxia, Morales-Nebreda, Luisa, Feng, Gang, Wu, Minghua, Zhou, Xiaodong, Lafyatis, Robert, Lee, Jungwha, Hinchcliff, Monique, Feghali-Bostwick, Carol, Lakota, Katja, Budinger, G. R. Scott, Raparia, Kirtee, Tamaki, Zenshiro, Varga, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895803/
https://www.ncbi.nlm.nih.gov/pubmed/27256716
http://dx.doi.org/10.1038/ncomms11703
_version_ 1782435927503667200
author Bhattacharyya, Swati
Wang, Wenxia
Morales-Nebreda, Luisa
Feng, Gang
Wu, Minghua
Zhou, Xiaodong
Lafyatis, Robert
Lee, Jungwha
Hinchcliff, Monique
Feghali-Bostwick, Carol
Lakota, Katja
Budinger, G. R. Scott
Raparia, Kirtee
Tamaki, Zenshiro
Varga, John
author_facet Bhattacharyya, Swati
Wang, Wenxia
Morales-Nebreda, Luisa
Feng, Gang
Wu, Minghua
Zhou, Xiaodong
Lafyatis, Robert
Lee, Jungwha
Hinchcliff, Monique
Feghali-Bostwick, Carol
Lakota, Katja
Budinger, G. R. Scott
Raparia, Kirtee
Tamaki, Zenshiro
Varga, John
author_sort Bhattacharyya, Swati
collection PubMed
description The factors responsible for maintaining persistent organ fibrosis in systemic sclerosis (SSc) are not known but emerging evidence implicates toll-like receptors (TLRs) in the pathogenesis of SSc. Here we show the expression, mechanism of action and pathogenic role of endogenous TLR activators in skin from patients with SSc, skin fibroblasts, and in mouse models of organ fibrosis. Levels of tenascin-C are elevated in SSc skin biopsy samples, and serum and SSc fibroblasts, and in fibrotic skin tissues from mice. Exogenous tenascin-C stimulates collagen gene expression and myofibroblast transformation via TLR4 signalling. Mice lacking tenascin-C show attenuation of skin and lung fibrosis, and accelerated fibrosis resolution. These results identify tenascin-C as an endogenous danger signal that is upregulated in SSc and drives TLR4-dependent fibroblast activation, and by its persistence impedes fibrosis resolution. Disrupting this fibrosis amplification loop might be a viable strategy for the treatment of SSc.
format Online
Article
Text
id pubmed-4895803
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-48958032016-08-18 Tenascin-C drives persistence of organ fibrosis Bhattacharyya, Swati Wang, Wenxia Morales-Nebreda, Luisa Feng, Gang Wu, Minghua Zhou, Xiaodong Lafyatis, Robert Lee, Jungwha Hinchcliff, Monique Feghali-Bostwick, Carol Lakota, Katja Budinger, G. R. Scott Raparia, Kirtee Tamaki, Zenshiro Varga, John Nat Commun Article The factors responsible for maintaining persistent organ fibrosis in systemic sclerosis (SSc) are not known but emerging evidence implicates toll-like receptors (TLRs) in the pathogenesis of SSc. Here we show the expression, mechanism of action and pathogenic role of endogenous TLR activators in skin from patients with SSc, skin fibroblasts, and in mouse models of organ fibrosis. Levels of tenascin-C are elevated in SSc skin biopsy samples, and serum and SSc fibroblasts, and in fibrotic skin tissues from mice. Exogenous tenascin-C stimulates collagen gene expression and myofibroblast transformation via TLR4 signalling. Mice lacking tenascin-C show attenuation of skin and lung fibrosis, and accelerated fibrosis resolution. These results identify tenascin-C as an endogenous danger signal that is upregulated in SSc and drives TLR4-dependent fibroblast activation, and by its persistence impedes fibrosis resolution. Disrupting this fibrosis amplification loop might be a viable strategy for the treatment of SSc. Nature Publishing Group 2016-06-03 /pmc/articles/PMC4895803/ /pubmed/27256716 http://dx.doi.org/10.1038/ncomms11703 Text en Copyright © 2016, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Bhattacharyya, Swati
Wang, Wenxia
Morales-Nebreda, Luisa
Feng, Gang
Wu, Minghua
Zhou, Xiaodong
Lafyatis, Robert
Lee, Jungwha
Hinchcliff, Monique
Feghali-Bostwick, Carol
Lakota, Katja
Budinger, G. R. Scott
Raparia, Kirtee
Tamaki, Zenshiro
Varga, John
Tenascin-C drives persistence of organ fibrosis
title Tenascin-C drives persistence of organ fibrosis
title_full Tenascin-C drives persistence of organ fibrosis
title_fullStr Tenascin-C drives persistence of organ fibrosis
title_full_unstemmed Tenascin-C drives persistence of organ fibrosis
title_short Tenascin-C drives persistence of organ fibrosis
title_sort tenascin-c drives persistence of organ fibrosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895803/
https://www.ncbi.nlm.nih.gov/pubmed/27256716
http://dx.doi.org/10.1038/ncomms11703
work_keys_str_mv AT bhattacharyyaswati tenascincdrivespersistenceoforganfibrosis
AT wangwenxia tenascincdrivespersistenceoforganfibrosis
AT moralesnebredaluisa tenascincdrivespersistenceoforganfibrosis
AT fenggang tenascincdrivespersistenceoforganfibrosis
AT wuminghua tenascincdrivespersistenceoforganfibrosis
AT zhouxiaodong tenascincdrivespersistenceoforganfibrosis
AT lafyatisrobert tenascincdrivespersistenceoforganfibrosis
AT leejungwha tenascincdrivespersistenceoforganfibrosis
AT hinchcliffmonique tenascincdrivespersistenceoforganfibrosis
AT feghalibostwickcarol tenascincdrivespersistenceoforganfibrosis
AT lakotakatja tenascincdrivespersistenceoforganfibrosis
AT budingergrscott tenascincdrivespersistenceoforganfibrosis
AT rapariakirtee tenascincdrivespersistenceoforganfibrosis
AT tamakizenshiro tenascincdrivespersistenceoforganfibrosis
AT vargajohn tenascincdrivespersistenceoforganfibrosis